NeuroSense Therapeutics Ltd. Expense From Share-based Payment Transactions With Employees
NeuroSense Therapeutics Ltd. (NRSN) reported Expense From Share-based Payment Transactions With Employees of $1.95 million for the 6-month period ending 2022-06-30, per its 6-K/A filed 2023-01-19.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2023-01-19
| Period end | Expense From Share-based Payment Transactions With Employees 6 month | Expense From Share-based Payment Transactions With Employees 12 month |
|---|---|---|
| 2022-06-30 | $1.95M 6-K/A · filed 2023-01-19 | |
| 2021-12-31 | $1.85M 6-K/A · filed 2023-01-19 | |
| 2021-06-30 | $420.00K 6-K/A · filed 2023-01-19 | |
| 2020-12-31 | $257.00K 20-F · filed 2022-04-14 | |
| 2019-12-31 | $137.00K 20-F · filed 2022-04-14 |